Cargando…
Early onset epileptic encephalopathy with a novel GABRB3 mutation treated effectively with clonazepam: A case report
RATIONALE: Early onset epileptic encephalopathy (EOEE) is one of the most serious early onset epilepsies. The etiopathology of this condition remains unclear, and recent evidence indicated that gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 (GABRB3) gene mutations might be associated with...
Autores principales: | Zhang, Yi, Lian, Yajun, Xie, Nanchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815790/ https://www.ncbi.nlm.nih.gov/pubmed/29390378 http://dx.doi.org/10.1097/MD.0000000000009273 |
Ejemplares similares
-
No Gain, Less Pain: GABRB3 Mutations in Epileptic Encephalopathy
por: Gallagher, Martin J.
Publicado: (2022) -
GABA(A) Receptor Coupling Junction and Pore GABRB3 Mutations are Linked to Early-Onset Epileptic Encephalopathy
por: Hernandez, Ciria C., et al.
Publicado: (2017) -
GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy
por: Papandreou, Apostolos, et al.
Publicado: (2015) -
Early diagnosis improving the outcome of an infant with epileptic encephalopathy with cytoplasmic FMRP interacting protein 2 mutation: Case report and literature review
por: Zhong, Min, et al.
Publicado: (2019) -
Gain-of-function GABRB3 variants identified in vigabatrin-hypersensitive epileptic encephalopathies
por: Absalom, Nathan L, et al.
Publicado: (2020)